Oncology
Pasi Antero Janne, MD PHD
Senior Vice President for Translational Medicine; Scientific Director, Belfer Center for Applied Cancer Science; Professor of Medicine, Harvard Medical School
Pasi A. Jänne, MD, PhD, is a thoracic medical oncologist specializing in lung cancer at Dana-Farber Cancer Institute in Boston, Massachusetts. He serves as Senior Vice President for Translational Medicine and Scientific Director of the Belfer Center for Applied Cancer Science. Dr. Jänne treats patients with non-small cell lung cancer (NSCLC), particularly those with epidermal growth factor receptor (EGFR) mutations, and develops targeted therapies including EGFR tyrosine kinase inhibitors. His c
30+
Years in Practice
Credentials
Board Certifications
- Medical Oncology (ABIM)
Education & Training
- University of Pennsylvania School of Medicine — MD, PhD (1996)
- Dana-Farber Cancer Institute/Massachusetts General Hospital — Fellowship, Medical Oncology (2001)
- Brigham and Women's Hospital — Residency, Internal Medicine
- Harvard University — Master’s Degree in Clinical Investigation (2002)
Peer Recognition
- American Association for Cancer Research — Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Research
2018
- American Cancer Society — Medal of Honor
2024
- European Society for Medical Oncology — Translational Research Award
2018
- Fondation ARC — Léopold Griffuel Prize in translational and clinical research
2022
- National Cancer Institute — Outstanding Investigator Award
2018
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Dana-Farber Cancer Institute
- Brigham and Women's Hospital
- Massachusetts General Hospital
Languages
English
Experience
30+ years in practice